Durata Therapeutics U S Limited is categorized under Wholesale Pharmaceutical Products in Chicago, IL and active since 2013.
Durata Therapeutics U S Limited was established in 2013, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Corey Fishman at the company’s single location by writing to 200 South Wacker Drive # 2550, Chicago, Illinois IL 60606 or by phoning (312) 219-7000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Durata Therapeutics U S Limited |
| Contact Person: | Corey Fishman |
| Address: | 200 South Wacker Drive # 2550, Chicago, Illinois 60606 |
| Phone Number: | (312) 219-7000 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Durata Therapeutics U S Limited was started in 2013 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Corey Fishman for inquiries that concern Durata Therapeutics U S Limited by calling the company number (312) 219-7000, as your correspondence is most welcome. Additionally, the physical location of the single location of Durata Therapeutics U S Limited can be found at the coordinates as well as the street address 200 South Wacker Drive # 2550 in Chicago, Illinois 60606.
For its online presence, you may visit Durata Therapeutics U S Limited’s website at and engage with its social media outlets through on Twitter and on Facebook.